In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.
- IgM monoclonal proteins
- Lymphoplasmacytic lymphoma
- Stem cell transplant
- Waldenström macroglobulinaemia
ASJC Scopus subject areas